Research and Development Archives - DelveInsight

Research and Development

Novo petitions FDA;J&J invests; Xarelto’s trial; Roche’s Tecentriq

Novo petitions FDA to require copies of Victoza to conduct clinical trials With one drugmaker already trying to pry patent protection off of Novo Nordisk’s blockbuster Victoza before its 2022 expir...


Friedrich’s ataxia: Rare disease

Friedreich's ataxia is one of the rare inherited nervous system disorder which causes movement abnormalities like slowed voluntary movement leading to gait disturbance and decreased coordination. I...


Default Blog Image
Natural Killer Cell Therapies– Advancing technology increasing competition among the companies

Natural killer cells are a type of lymphocytes and are key components of the innate immune system. They are highly specific predators that play a major role in the host rejection of both tumors and...


Innovate the UK, aiming to drive efforts to commercialize research

The government of UK announced an extra £4.7 billion (US$6.1 billion) into research and development (R&D) by 2020–21, which allayed the fears of many UK scientists which had erupted ahead of Br...


China cracks down on fake peer reviews

The Chinese government is going on the offensive against scientists who dupe journals by creating fraudulent reviews of submitted papers. A coalition of agencies led by the science ministry announc...


Urinary Tract Infections (UTIs)– How is it affecting the Globe?

Urinary tract infections (UTIs) are caused by microbes, such as bacteria, by overcoming the body's immune defenses in the urinary tract. They can affect different parts of the urinary tract which i...


Scientists relieved by Emmanuel Macron’s French election victory

French scientists say they’re relieved and happy that their country’s next president will be Emmanuel Macron, a 39-year-old former civil servant and economy minister who swept to victory in electio...


Cytomegalovirus infection Market

Cytomegalovirus (CMV) infection is a major Herpes virus infection, which is the leading cause of morbidity and mortality worldwide among congenitally infected newborns, HIV/AIDS patients and t...


Pulling the apoptotic trigger for necrosis

Apoptosis and necrosis are considered to be distinct modes of cell death; however, apoptosis can progress to secondary necrosis if apoptotic cells are not efficiently removed by phagocytic cells. S...


CDC study reveals; Jevtana receives yes; Herantis secures; Immuno-oncology is not cost-effective

CDC study reveals Zika virus replicates in foetal brain and placentas Study conducted by the US Centers for Disease Control and Prevention (CDC) has revealed that the Zika virus replicates in the b...


Editor's Pick
Top Drugs To Watch in HIV (2025)

Human Immunodeficiency Virus or HIV is a species of Lentivirus (genus of retrovirus) th...

An in-depth Assessment of the Top Drugs Launched by Leading Global Companies ...

Progress is driven by innovation. When it comes to developing novel medications and the...

Changing Dynamics of HIV-1 Treatment Market

The HIV-1 treatment market for naïve and experienced patients is evolving consistently....

Which Countries Top the Chart in Global Pharmaceutical Market?

The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...

von Willebrand disease (VWD) – Misdiagnosis Still Prevalent!

Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.